Individualized assessment of radiation dose in patients undergoing coronary computed tomographic angiography with 256-slice scanning

CT Scans and Cancer Risks: A Systematic Review and Dose-response Meta-analysis

BACKGROUND

There is still uncertainty on whether ionizing radiation from CT scans can increase the risks of cancer. This study aimed to identify the association of cumulative ionizing radiation from CT scans with pertaining cancer risks in adults.

METHODS

Five databases were searched from their inception to November 15, 2020. Observational studies reporting cancer risks from CT scans in adults were included. The main outcome included quantified cancer risks as cancer case numbers in exposed/unexposed adult participants with unified converted measures to odds ratio (OR) for relative risk, hazard ratio. Global background radiation (2.4 mSv per year) was used as control for lifetime attribution risk (LAR), with the same period from incubation after exposure until survival to 100 years.

RESULTS

25 studies were included with a sum of 111,649,943 participants (mean age: 45.37 years, 83.4% women), comprising 2,049,943 actual participants from 6 studies with an average follow-up period as 30.1 years (range, 5 to 80 years); 109,600,000 participants from 19 studies using LAR. The cancer risks for adults following CT scans were inordinately increased (LAR adults, OR, 10.00 [95% CI, 5.87 to 17.05]; actual adults, OR, 1.17 [95%CI, 0.89 to 1.55]; combined, OR, 5.89 [95%CI, 3.46 to 10.35]). Moreover, cancer risks elevated with increase of radiation dose (OR, 33.31 [95% CI, 21.33 to 52.02]), and multiple CT scan sites (OR, 14.08 [95% CI, 6.60 to 30.05]). The risk of solid malignancy was higher than leukemia. Notably, there were no significant differences for age, gender, country, continent, study quality and studying time phrases.

CONCLUSIONS

Based on 111.6 million adult participants from 3 continents (Asia, Europe and America), this meta-analysis identifies an inordinately increase in cancer risks from CT scans for adults. Moreover, the cancer risks were positively correlated with radiation dose and CT sites. The meta-analysis highlights the awareness of potential cancer risks of CT scans as well as more reasonable methodology to quantify cancer risks in terms of life expectancy as 100 years for LAR.

PROSPERO TRIAL REGISTRATION NUMBER

CRD42019133487.

Gender based lung cancer risks for symptomatic coronary artery disease patients undergone cardiac CT

We estimate the lifetime attributable risk (LAR) of lung cancer incidence in symptomatic Coronary Artery Disease (CAD) patients receiving enhanced Coronary Computed Tomography Angiography (CCTA) and the unenhanced Computed Tomography Calcium Scoring (CTCS) examination. Retrospective analysis has been made of CCTA and CTCS data collected for 87 confirmed CAD adult patients. Patient effective dose (E) and organ doses (ODs) were calculated using CT-EXPO. Statistical correlation and the differences between E and ODs in enhanced CCTA and unenhanced CTCS were calculated using the Pearson coefficient and Wilcoxon unpaired t-test. Following BEIR VII report guidance, organ-specific LARs for the cohort were estimated using the organ-equivalent dose-to-risk conversion factor for numbers of cases per 100,000 patients exposed to low doses of 0.1 Gy. Significant statistical difference (p<0.0001) is found between E obtained for CTCS and that of CCTA. The scan length was found to be greater in CCTA (17.5 ± 2.9 cm) compared to that for CTCS (15 ± 2 cm). More elevated values of dose were noted for the esophagus (4.2 ± 2.15 mSv) and thymus (9.6 ± 2.54 mSv) for both CTCS and CCTA. CTCS organ doses were lower than that of CCTA. Per 100,000 patients, female cumulative doses are seen to give rise to greater lung cancer LARs compared to that for males, albeit with risk varying significantly, noticeably greater for females, younger patients and combined CCTA and CTCS scans. While scan parameters and tube-modulation methods clearly contribute to patient dose, mAs offers by far the greater contribution.

Evaluation of an organ-based tube current modulation tool in pediatric CT examinations

Objectives

To investigate the effect of an organ-based tube current modulation (OTCM) technique on organ absorbed dose and assess image quality in pediatric CT examinations.

Methods

Four physical anthropomorphic phantoms that represent the average individual as neonate, 1-year-old, 5-year-old, and 10-year-old were used. Standard head and thorax acquisitions were performed with automatic tube current modulation (ATCM) and ATCM+OTCM. Dose calculations were performed by means of Monte Carlo simulations. Radiation dose was measured for superficial and centrally located radiosensitive organs. The angular range of the OTCM exposure window was determined for different tube rotation times (t) by means of a solid-state detector. Image noise was measured as the standard deviation of the Hounsfield unit value in regions of interest drawn at selected anatomical sites.

Results

ATCM+OTCM resulted in a reduction of radiation dose to all radiosensitive organs. In head, eye lens dose was reduced by up to 13% in ATCM+OTCM compared with ATCM. In thorax, the corresponding reduction for breast dose was up to 10%. The angular range of the OTCM exposure window decreased with t. For t = 0.4 s, the angular range was limited to 74° in head and 135° for thorax. Image noise was significantly increased in ATCM+OTCM acquisitions across most examined phantoms (p < 0.05).

Conclusions

OTCM reduces radiation dose to exposed radiosensitive organs with the eye lens and breast buds exhibiting the highest dose reduction. The OTCM exposure window is narrowed at short t. An increase in noise is inevitable in images located within the OTCM-activated imaged volume.

Key Points

• In pediatric CT, organ-based tube current modulation reduces radiation dose to all major primarily exposed radiosensitive organs.

• Image noise increases within the organ-based tube current modulation enabled imaged volume.

• The angular range of the organ-based tube current modulation low exposure window is reduced with tube rotation time.

Organ Doses, Effective Dose, and Cancer Risk From Coronary CT Angiography Examinations

OBJECTIVE. The purposes of this study were to determine organ and effective doses and to estimate the risk of exposure-induced cancer death (REID) associated with coronary CT angiography (CCTA) examinations. SUBJECTS AND METHODS. CCTA examinations were performed in three stages: calcium score, monitoring, and cardiac phases for all patients. Effective dose was calculated using two methods. The first was based on the scanner-derived dose-length product, and the second entailed use of an organ and effective dose calculator software application. Organ doses were calculated on the basis of the tissue weighting factors of International Commission on Radiation Protection report 103. REID values were assessed with a cancer risk estimator software application. RESULTS. The study included 185 patients (95 men, 90 women). For women, breast doses were high at 52.04 ± 14.08 mGy. The mean effective dose in the women was greater than that in the men (24.05 vs 16.30 mSv, p < 0.05). The mean REID values in patients undergoing CCTA with a 64-MDCT scanner were 13.4 per 10,000 men (1 in 746) and 19.6 per 10,000 women (1 in 508). The REID values were considerably higher for the younger women. CONCLUSION. The results of this study will help referring physicians justify requesting CCTA examinations by considering their benefits for diagnosis on the one hand and awareness of the risk of radiation-induced cancer on the other. In the case of CCTA scans that are properly justified by clinical indication, patients and physicians should not be concerned about the radiation risks.

Organ Doses and Radiation Risk of Computed Tomographic Coronary Angiography in a Clinical Patient Population: How Do Low-Dose Acquisition Modes Compare?

OBJECTIVE

To compare the organ doses and lifetime-attributable risk of cancer for electrocardiogram-triggered sequential and high-pitch helical scanning in a clinical patient population.

METHODS

Phantom thermoluminiscence dosimeter measurements were used as a model for the organ dose assessment of 314 individual patients who underwent coronary computed tomographic angiography. Patient-specific lifetime-attributable cancer risks were calculated.

RESULTS

Phantom measurements showed that heart rate had a significant influence on the delivered radiation exposure in sequential mode, and calcium scoring and contrast bolus tracking scans make a nonnegligible contribution to patients' dose. Therefore, they should be taken into account for patients' organ dose estimations. Median cancer induction risks are low, with 0.008% (0.0016%) and 0.022% (0.056%) for high-pitch and sequential scanning for men (women), respectively.

CONCLUSIONS

The use of high-pitch helical scanning leads to 65% and 72% lower lifetime-attributable risk values for men and women, respectively, compared with sequential scanning.

Radiation risks associated with serial imaging in colorectal cancer patients: Should we worry?

To provide an overview of the radiation related cancer risk associated with multiple computed tomographic scans required for follow up in colorectal cancer patients. A literature search of the PubMed and Cochrane Library databases was carried out and limited to the last 10 years from December 2012. Inclusion criteria were studies where computed tomographic scans or radiation from other medical imaging modalities were used and the risks associated with ionizing radiation reported. Thirty-six studies were included for appraisal with no randomized controlled trials. Thirty-four of the thirty-six studies showed a positive association between medical imaging radiation and increased risk of cancer. The radiation dose absorbed and cancer risk was greater in children and young adults than in older patients. Most studies included in the review used a linear, no-threshold model to calculate cancer risks and this may not be applicable at low radiation doses. Many studies are retrospective and ensuring complete follow up on thousands of patients is difficult. There was a minor increased risk of cancer from ionizing radiation in medical imaging studies. The radiation risks of low dose exposure (< 50 milli-Sieverts) are uncertain. A clinically justified scan in the context of colorectal cancer is likely to provide more benefits than harm but current guidelines for patient follow up will need to be revised to accommodate a more aggressive approach to treating metastatic disease.

Personalized assessment of radiation risks from the one-stop-shop myocardial 256-slice CT examination

BACKGROUND

This study provides data on the cumulative life attributable risk (LAR) of radiation-induced cancer from the combination of coronary CT angiography (CCTA), dynamic CT perfusion (CTP) and delayed enhancement (DE) CT scans, required for reliable risk-benefit analysis of the one-stop-shop CCTA + CTP + DECT cardiac examination.

METHODS

Monte Carlo simulation of the dynamic CTP and DECT exposures on 62 adult individuals was employed to determine radiation absorbed dose to exposed radiosensitive organs. Corresponding data for CCTA were derived using patient chest circumference and previously published data. Individual-specific LARs of cancer were estimated using organ/tissue-specific radiogenic cancer risk factors. Total LAR from CCTA + CTP + DECT scans' sequence were estimated and compared to nominal intrinsic risk of cancer.

RESULTS

The main contribution, up to 80%, to cumulative radiation burden from CCTA + CTP + DECT scan-sequence was found to originate from the CTP scan. The total LAR from CCTA + CTP + DECT for females was found 4-6 times higher, compared to males. The mean cumulative risk of radiogenic cancer associated with the complete CCTA + CTP + DECT scan sequence was found to marginally increase the intrinsic risk for cancer induction by less than 0.6% and 0.1% for females and males, respectively.

CONCLUSIONS

The radiation risk from the 256-slice CCTA + CTP + DECT scan sequence may be considered low and should not constitute an obstacle for the clinical endorsement of the one-stop-shop cardiac CT examination, given that its clinical value has been well verified. Nevertheless, every effort should be made towards optimization of the dynamic CTP component which is the main contributor to patient radiation burden.

Comparison of coronary CT angiography image quality with and without breast shields

OBJECTIVE

The purpose of this study is to compare the image quality of coronary CT angiography performed with and without breast shields.

MATERIALS AND METHODS

This study involved a retrospective cohort of 72 women with possible angina who underwent 64-MDCT retrospective ECG-gated coronary CT angiography at a single academic tertiary medical center. Images of 36 women scanned while wearing bismuth-coated latex breast shields and 36 control subjects scanned without shields, matched by heart rate and body mass index, were graded on a standardized Likert scale for image quality, stenosis, and plaque by two independent board-certified readers blinded to breast shields.

RESULTS

Seventy-two patients (mean [± SD] age, 53 ± 9 years) were included. The pre scan heart rate, body mass index, and Agatston score did not differ between groups. The median estimated radiation dose was 13.4 versus 16.1 mSv for those with and without breast shields (p = 0.003). For shielded versus unshielded scans, 86% versus 83% of coronary segments were rated excellent or above average (p = 0.4), median image quality was 2.0 for both groups, mean signal was 474 ± 75 and 452 ± 91 HU (p = 0.27), mean noise was 33.9 ± 8.5 and 29.8 ± 8.3 HU (p = 0.04), and median signal-to-noise ratio was 14.4 and 14.7 (p = 0.56), respectively.

CONCLUSION

Breast shields for women undergoing coronary CT angiography slightly increased noise but did not negatively affect signal, signal-to-noise ratio, quality, or interpretability. Breast shield use warrants further study.

The effect of head size∕shape, miscentering, and bowtie filter on peak patient tissue doses from modern brain perfusion 256-slice CT: how can we minimize the risk for deterministic effects?

PURPOSE

To determine patient-specific absorbed peak doses to skin, eye lens, brain parenchyma, and cranial red bone marrow (RBM) of adult individuals subjected to low-dose brain perfusion CT studies on a 256-slice CT scanner, and investigate the effect of patient head size∕shape, head position during the examination and bowtie filter used on peak tissue doses.

METHODS

The peak doses to eye lens, skin, brain, and RBM were measured in 106 individual-specific adult head phantoms subjected to the standard low-dose brain perfusion CT on a 256-slice CT scanner using a novel Monte Carlo simulation software dedicated for patient CT dosimetry. Peak tissue doses were compared to corresponding thresholds for induction of cataract, erythema, cerebrovascular disease, and depression of hematopoiesis, respectively. The effects of patient head size∕shape, head position during acquisition and bowtie filter used on resulting peak patient tissue doses were investigated. The effect of eye-lens position in the scanned head region was also investigated. The effect of miscentering and use of narrow bowtie filter on image quality was assessed.

RESULTS

The mean peak doses to eye lens, skin, brain, and RBM were found to be 124, 120, 95, and 163 mGy, respectively. The effect of patient head size and shape on peak tissue doses was found to be minimal since maximum differences were less than 7%. Patient head miscentering and bowtie filter selection were found to have a considerable effect on peak tissue doses. The peak eye-lens dose saving achieved by elevating head by 4 cm with respect to isocenter and using a narrow wedge filter was found to approach 50%. When the eye lies outside of the primarily irradiated head region, the dose to eye lens was found to drop to less than 20% of the corresponding dose measured when the eye lens was located in the middle of the x-ray beam. Positioning head phantom off-isocenter by 4 cm and employing a narrow wedge filter results in a moderate reduction of signal-to-noise ratio mainly to the peripheral region of the phantom.

CONCLUSIONS

Despite typical peak doses to skin, eye lens, brain, and RBM from the standard low-dose brain perfusion 256-slice CT protocol are well below the corresponding thresholds for the induction of erythema, cataract, cerebrovascular disease, and depression of hematopoiesis, respectively, every effort should be made toward optimization of the procedure and minimization of dose received by these tissues. The current study provides evidence that the use of the narrower bowtie filter available may considerably reduce peak absorbed dose to all above radiosensitive tissues with minimal deterioration in image quality. Considerable reduction in peak eye-lens dose may also be achieved by positioning patient head center a few centimeters above isocenter during the exposure.

Screening computed tomography colonography with 256-slice scanning: should patient radiation burden and associated cancer risk constitute a major concern?

OBJECTIVES

The aim of this study was to determine the radiation burden and the lifetime attributable risk (LAR) of radiation-induced cancer in patients undergoing screening 256-slice computed tomography colonography (CTC) and compare CTC-related radiogenic risks to corresponding nominal lifetime intrinsic risk of cancer.

MATERIALS AND METHODS

A Monte Carlo simulation software dedicated for computed tomography (CT) dosimetry was used to determine absorbed doses to primarily exposed radiosensitive organs of 31 women and 29 men subjected to screening CTC on a 256-slice CT scanner. Effective dose was estimated from (a) organ dose data and (b) dose-length product. Organ-specific and total LARs of cancer were estimated using published risk factors. Cumulative LARs from repeated CTC studies on individuals participating in a colorectal cancer screening program were compared with corresponding lifetime intrinsic risks.

RESULTS

The mean organ dose-derived effective dose was estimated to be 2.92 and 2.61 mSv for female and male individuals, respectively. The dose-length product method was found to overestimate effective dose from CTC by 26% and 13% in female and male individuals, respectively. Compared with previously published results for 64-slice CT scanners, 256-slice CTC was found to be associated with up to 45% less radiation burden. The cumulative LAR of radiation-induced cancer from repeated quinquennial screening CTC studies between the ages of 50 and 80 years was estimated to increase the lifetime intrinsic risk of cancer by less than 0.2%.

CONCLUSION

The level of patient radiation burden and theoretical radiogenic cancer risks associated with screening CTC performed using modern low-dose protocols and techniques may not justify disapproval of CTC as a mass screening tool.

Fast on-site Monte Carlo tool for dose calculations in CT applications

PURPOSE

Monte Carlo (MC) simulation is an established technique for dose calculation in diagnostic radiology. The major drawback is its high computational demand, which limits the possibility of usage in real-time applications. The aim of this study was to develop fast on-site computed tomography (CT) specific MC dose calculations by using a graphics processing unit (GPU) cluster.

METHODS

GPUs are powerful systems which are especially suited to problems that can be expressed as data-parallel computations. In MC simulations, each photon track is independent of the others; each launched photon can be mapped to one thread on the GPU, thousands of threads are executed in parallel in order to achieve high performance. For further acceleration, the authors considered multiple GPUs. The total computation was divided into different parts which can be calculated in parallel on multiple devices. The GPU cluster is an MC calculation server which is connected to the CT scanner and computes 3D dose distributions on-site immediately after image reconstruction. To estimate the performance gain, the authors benchmarked dose calculation times on a 2.6 GHz Intel Xeon 5430 Quad core workstation equipped with two NVIDIA GeForce GTX 285 cards. The on-site calculation concept was demonstrated for clinical and preclinical datasets on CT scanners (multislice CT, flat-detector CT, and micro-CT) with varying geometry, spectra, and filtration. To validate the GPU-based MC algorithm, the authors measured dose values on a 64-slice CT system using calibrated ionization chambers and thermoluminesence dosimeters (TLDs) which were placed inside standard cylindrical polymethyl methacrylate (PMMA) phantoms.

RESULTS

The dose values and profiles obtained by GPU-based MC simulations were in the expected good agreement with computed tomography dose index (CTDI) measurements and reference TLD profiles with differences being less than 5%. For 10(9) photon histories simulated in a 256 × 256 × 12 voxel thorax dataset with voxel size of 1.36 × 1.36 × 3.00 mm(3), calculation times of about 70 and 24 min were necessary with single-core and multiple-core central processing unit (CPU) solutions, respectively. Using GPUs, the same MC calculations were performed in 1.27 min (single card) and 0.65 min (two cards) without a loss in quality. Simulations were thus speeded up by factors up to 55 and 36 compared to single-core and multiple-core CPU, respectively. The performance scaled nearly linearly with the number of GPUs. Tests confirmed that the proposed GPU-based MC tool can be easily adapted to different types of CT scanners and used as service providers for fast on-site dose calculations.

CONCLUSIONS

The Monte Carlo software package provides fast on-site calculation of 3D dose distributions in the CT suite which makes it a practical tool for any type of CT-specific application.

Triple-rule-out computed tomography angiography with 256-slice computed tomography scanners: patient-specific assessment of radiation burden and associated cancer risk

OBJECTIVES

Risk-benefit analysis of triple-rule-out 256-slice computed tomography angiography (TRO-CTA) requires data on associated cancer risks, currently not available. The aim of the current study was to provide estimates of patient radiation burden and lifetime attributable risk (LAR) of radiation-induced cancer in patients undergoing typical 256-slice TRO-CTA.

MATERIALS AND METHODS

Standard step-and-shoot 256-slice TRO-CTA exposures were simulated on 31 male and 31 female individual-specific voxelized phantoms using a Monte Carlo CT dosimetry software. Dose images were generated depicting the dose deposition on the exposed body region of the patient. Organ doses were obtained for all primarily irradiated radiosensitive organs. Organ doses were correlated to patient body size. TRO-CTA effective dose was estimated from (a) organ doses and (b) dose-length product data. Recently published sex-, age-, and organ-specific cancer risk factors were used to estimate the total LAR of radiation-induced cancer. The theoretical risks of radiation-induced cancer to the lung and breast following a 256-slice TRO-CTA were compared with the corresponding nominal risks for each of the studied patients.

RESULTS

The highest organ doses were observed for the breast, heart, esophagus, and lung. Mean effective dose estimated using organ dose data was found to be 6.5 ± 1.0 mSv for female and 3.8 ± 0.7 mSv for male individuals subjected to 256-slice TRO-CTA. The associated mean LARs of cancer was found to be 41 per 10 female and 17 per 10 male patients. The total radiation-induced cancer risk was found to markedly decrease with patient age. TRO-CTA exposure was found to increase the intrinsic risks of developing lung or breast cancer during the remaining lifetime by less than 0.5% and 0.1%, respectively.

CONCLUSIONS

The mean theoretical risk of radiation-induced cancer for a patient cohort subjected to step-and-shoot 256-slice TRO-CTA may be considered to be low compared with the intrinsic risk of developing cancer.

[State of the art: new developments in cardiac imaging]

Cardiac imaging continues to reveal new anatomical and functional insights into heart disease. In echocardiography, both transesophageal and transthoracic three-dimensional imaging have been fully developed and optimized, and the value of the techniques that have increased our understanding of cardiac mechanics and ventricular function is well established. At the same time, the healthcare industry has released new devices onto the market which, although they are easier to use, have limitations that restrict their use for routine assessment. Tomography's diagnostic and prognostic value in coronary artery disease continues to increase while radiation exposure becomes progressively lower. With cardiac magnetic resonance imaging, myocardial injury and recovery in ischemic heart disease and following acute coronary syndrome can be monitored in exquisite detail. The emergence of new combined tomographic and gamma camera techniques, exclusively developed for nuclear cardiology, have improved the quality of investigations and reduced radiation exposure. The hybrid or fusion images produced by combining different techniques, such as nuclear cardiology techniques and tomography, promise an exciting future.